Immunopathogenesis and immunotherapy of multiple sclerosis
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Neurology
- Vol. 2 (4) , 201-211
- https://doi.org/10.1038/ncpneuro0154
Abstract
Nature Clinical Practice Neurology will deliver timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief and international Advisory Board will ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of Nature Publishing Group.Keywords
This publication has 92 references indexed in Scilit:
- Natalizumab and Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2005
- CHEMOKINES, SPHINGOSINE-1-PHOSPHATE, AND CELL MIGRATION IN SECONDARY LYMPHOID ORGANSAnnual Review of Immunology, 2005
- Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in RatsJournal of Neuroscience, 2004
- Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patientsEuropean Journal of Immunology, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Combination of Gene Delivery and DNA Vaccination to Protect from and Reverse Th1 Autoimmune Disease via Deviation to the Th2 PathwayImmunity, 2001
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Determinant spreading and the dynamics of the autoimmune T-cell repertoireImmunology Today, 1993
- Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new viewImmunology Today, 1992